Deaths from Amyloidosis

Survival rate statistics for Amyloidosis

The following are statistics from various sources about the survival rate for Amyloidosis:

1 year is the median survival rate for patients who have a liver biopsy to treat amyloidosis in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
Symptomatic congestive heart failure has a median survival of 4 to 6 months in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
8 months is the median survival for amyloidosis patients from the onset of myelodysplasia in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
Amyloid patients with cardiac involvement who undergo heart transplant have a 100% 1 year survival rate in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
Amyloid patients with cardiac involvement who undergo heart transplant have a 83.3% 2 year survival rate in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)
The five year survival rate for secondary AA Amyloidosis is about 50% in the US (Amloidosis Support Network)
The 1 year survival rate for patients with primary systemic amyloidosis who undergo peripheral blood stem cell transplantation is 89% (Blood. 2004;103:3960-3963, The American Society of Hematology)
The 1 year survival rate for patients with primary systemic amyloidosis who don’t undergo peripheral blood stem cell transplantation is 55% (Blood. 2004;103:3960-3963, The American Society of Hematology)
The 2 year survival rate for patients with primary systemic amyloidosis who undergo peripheral blood stem cell transplantation is 71% (Blood. 2004;103:3960-3963, The American Society of Hematology)
The 2 year survival rate for patients with primary systemic amyloidosis who don’t undergo peripheral blood stem cell transplantation is 71% (Blood. 2004;103:3960-3963, The American Society of Hematology)
The 4 year survival rate for patients with primary systemic amyloidosis who undergo peripheral blood stem cell transplantation is 81% ((Blood. 2004;103:3960-3963, The American Society of Hematology)
The 4 year survival rate for patients with primary systemic amyloidosis who don’t undergo peripheral blood stem cell transplantation is 41% (Blood. 2004;103:3960-3963, The American Society of Hematology)
The median survival rate for AL amyloidosis is 12-18 months in the US (The Mayo Clinic)
51% is the 1 year survival rate for patients with AL Amyloidosis (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)
16% is the 5 year survival rate for patients with AL Amyloidosis (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)
4.7% is the 10 year survival rate for patients with AL Amyloidosis (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)
100% of AL amyloidosis patients who survived more than 10 years had received alkylating-agent therapy (Long-Term Survival in 30 Patients With Primary Amyloidosis, The American Society of Hematology, 1999)

Death statistics for Amyloidosis

The following are statistics from various sources about deaths and Amyloidosis:

35% of deaths from secondary AA amyloidosis is due to end-stage renal failure resulting from untreated secondary AA amyloidosis n the US (Amyloidosis Support Network)

Amyloidosis: Hospitalization Statistics

The following are statistics from various sources about hospitalizations and Amyloidosis:

0.008% (995) of hospital consultant episodes were for amyloidosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
86% of hospital consultant episodes for amyloidosis required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
57% of hospital consultant episodes for amyloidosis were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
43% of hospital consultant episodes for amyloidosis were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
more stats »